This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Biogen Idec Ma Inc., Biogen Ma Inc.. Active years: 2013-2016.
Location History:
- Cary, NC (US) (2013 - 2015)
- San Mateo, CA (US) (2016)
Company Filing History:
Years Active: 2013-2016
Title: Eric Scharin: Innovator in Liquid Interferon Formulations
Introduction
Eric Scharin is a notable inventor based in Cary, NC (US), recognized for his contributions to the field of biopharmaceuticals. He holds a total of 4 patents, focusing primarily on stable liquid formulations of interferon beta. His work has significant implications for the treatment of various medical conditions.
Latest Patents
Scharin's latest patents include innovative formulations of liquid interferon compositions. These compositions maintain a pH between 4.0 and 7.2 and comprise interferon-beta along with a stabilizing agent, which is an amino acid selected from a specific group. The stabilizing agent is present at a concentration of about 0.3% to 5% by weight. If necessary, salt is added to ensure sufficient ionic strength. Notably, the liquid composition has not been previously lyophilized or cavitated. The formulations are designed to be contained within vessels that have surfaces coated with materials inert to the adsorption of interferon-beta. Additionally, Scharin has developed a kit for the parenteral administration of these liquid formulations and a method for stabilizing them.
Career Highlights
Throughout his career, Eric Scharin has worked with prominent companies in the biopharmaceutical sector, including Biogen Idec MA Inc. and Biogen MA Inc. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Scharin has collaborated with notable colleagues such as Wen-Li Chung and Mary Diana DiBiase. These partnerships have played a crucial role in advancing his research and patent developments.
Conclusion
Eric Scharin's work in the field of liquid interferon formulations showcases his innovative spirit and dedication to improving medical treatments. His patents reflect significant advancements that could enhance the stability and efficacy of interferon therapies.